Healthcare provider profile · identity verified

Scott A Sheldon, MD

Allopathic & Osteopathic Physicians|Internal Medicine · WINSTON SALEM, NC · NPI 1265475685

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Scott A Sheldon, MD received $207.42 in general payments during 2025 across 3 reported records.

Otsuka Pharmaceutical Development & Commercialization, Inc. accounted for 45.7% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 3 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Nuplazid.

ACADIA Pharmaceuticals Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NUPLAZID as an associated drug or biological on 20845 records involving 6448 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Nuplazid by this doctor in 2024.

E.R. Squibb & Sons, L.L.C. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 27956 records involving 14870 distinct recipient NPIs. Public Medicare Part D data also shows 419 claims for Eliquis by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$207.42

3 reported records · 3 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Otsuka Pharmaceutical Development & Commercialization, Inc.	Unresolved — no canonical attribution shown	$94.72	45.7%	1	2025
ACADIA Pharmaceuticals Inc	Unresolved — no canonical attribution shown	$92.27	44.5%	1	2025
E.R. Squibb & Sons, L.L.C.	Unresolved — no canonical attribution shown	$20.43	9.8%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$207.42	3

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
REXULTI Normalized: rexulti	Drug	Otsuka Pharmaceutical Development & Commercialization, Inc.	$94.72	1	2025
Source payment records 2025-10-29 · Otsuka Pharmaceutical Development & Commercialization, Inc. · $94.72 · Open Payments source
NUPLAZID Normalized: nuplazid	Drug	ACADIA Pharmaceuticals Inc	$92.27	1	2025
Source payment records 2025-03-13 · ACADIA Pharmaceuticals Inc · $92.27 · Open Payments source
COBENFY Normalized: cobenfy	Drug	E.R. Squibb & Sons, L.L.C.	$20.43	1	2025
Source payment records 2025-09-02 · E.R. Squibb & Sons, L.L.C. · $20.43 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
NUPLAZID nuplazid	2025	Nuplazid	2024	13 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
ACADIA Pharmaceuticals Inc Exact reporting entity; no affiliate inference	2025	NUPLAZID open payments reported associated product	CMS Open Payments — General Payments 20845 supporting records · 6448 recipient NPIs · example record 1247763852	Nuplazid · 2024 Exact normalized brand match · 1 Part D row	13	suppressed by CMS
E.R. Squibb & Sons, L.L.C. Exact reporting entity; no affiliate inference	2025	ELIQUIS open payments reported associated product	CMS Open Payments — General Payments 27956 supporting records · 14870 recipient NPIs · example record 1184377713	Eliquis · 2024 Exact normalized brand match · 1 Part D row	419	66

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	591	88
Atorvastatin Calcium	Atorvastatin Calcium	562	97
Amlodipine Besylate	Amlodipine Besylate	519	86
Eliquis	Apixaban	419	66
Gabapentin	Gabapentin	411	79
Furosemide	Furosemide	386	92
Potassium Chloride	Potassium Chloride	380	67
Metoprolol Succinate	Metoprolol Succinate	356	62
Memantine Hcl	Memantine Hcl	293	37
Pantoprazole Sodium	Pantoprazole Sodium	250	61
Losartan Potassium	Losartan Potassium	236	40
Tamsulosin Hcl	Tamsulosin Hcl	233	48
Donepezil Hcl	Donepezil Hcl	228	35
Omeprazole	Omeprazole	228	58
Mirtazapine	Mirtazapine	224	38
Lisinopril	Lisinopril	215	41
Carvedilol	Carvedilol	211	42
Escitalopram Oxalate	Escitalopram Oxalate	200	42
Famotidine	Famotidine	198	37
Sertraline Hcl	Sertraline Hcl	194	38
Myrbetriq	Mirabegron	189	17
Duloxetine Hcl	Duloxetine Hcl	178	33
Metoprolol Tartrate	Metoprolol Tartrate	178	31
Clopidogrel	Clopidogrel Bisulfate	170	28
Trazodone Hcl	Trazodone Hcl	157	39
Torsemide	Torsemide	138	25
Latanoprost	Latanoprost	121	20
Divalproex Sodium	Divalproex Sodium	115	20
Prednisone	Prednisone	112	29
Metformin Hcl	Metformin Hcl	105	18
Levetiracetam	Levetiracetam	104	16
Xarelto	Rivaroxaban	103	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	100	48
Finasteride	Finasteride	100	21
Pravastatin Sodium	Pravastatin Sodium	100	18
Carbidopa-Levodopa	Carbidopa/Levodopa	98	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	98	14
Lorazepam	Lorazepam	97	41
Tramadol Hcl	Tramadol Hcl	96	36
Buspirone Hcl	Buspirone Hcl	92	22
Fluticasone Propionate	Fluticasone Propionate	91	30
Quetiapine Fumarate	Quetiapine Fumarate	90	23
Allopurinol	Allopurinol	89	19
Brimonidine Tartrate	Brimonidine Tartrate	88	14
Oxycodone Hcl	Oxycodone Hcl	87	31
Hydrochlorothiazide	Hydrochlorothiazide	86	12
Hydralazine Hcl	Hydralazine Hcl	85	28
Montelukast Sodium	Montelukast Sodium	80	13
Januvia	Sitagliptin Phosphate	79	suppressed
Lamotrigine	Lamotrigine	79	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	77	18
Ropinirole Hcl	Ropinirole Hcl	71	12
Breo Ellipta	Fluticasone/Vilanterol	70	suppressed
Fluconazole	Fluconazole	66	28
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	65	15
Hydroxyzine Hcl	Hydroxyzine Hcl	65	23
Ipratropium Bromide	Ipratropium Bromide	62	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	62	suppressed
Jardiance	Empagliflozin	61	12
Simvastatin	Simvastatin	60	suppressed
Ceftriaxone	Ceftriaxone Sodium	59	37
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	59	11
Linzess	Linaclotide	57	12
Paroxetine Hcl	Paroxetine Hcl	57	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	55	31
Risperidone	Risperidone	55	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	54	35
Fluvoxamine Maleate	Fluvoxamine Maleate	53	12
Alprazolam	Alprazolam	52	11
Primidone	Primidone	52	suppressed
Methenamine Hippurate	Methenamine Hippurate	51	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	50	14
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	50	suppressed
Baclofen	Baclofen	48	suppressed
Cefuroxime	Cefuroxime Axetil	48	20
Ezetimibe	Ezetimibe	48	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	47	30
Azithromycin	Azithromycin	47	17
Amiodarone Hcl	Amiodarone Hcl	46	13
Atenolol	Atenolol	46	suppressed
Bupropion Xl	Bupropion Hcl	44	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	44	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	44	24
Lactulose	Lactulose	44	11
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	43	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	42	13
Celecoxib	Celecoxib	39	12
Methimazole	Methimazole	39	suppressed
Ondansetron Odt	Ondansetron	39	25
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	39	19
Arexvy	Rsvpref3 Antigen/As01e/Pf	38	38
Enoxaparin Sodium	Enoxaparin Sodium	38	suppressed
Ertapenem	Ertapenem Sodium	38	12
Fluoxetine Hcl	Fluoxetine Hcl	38	11
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	38	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	37	11
Lidocaine Hcl	Lidocaine Hcl/Pf	37	17
Spironolactone	Spironolactone	37	suppressed
Aripiprazole	Aripiprazole	36	suppressed
Propranolol Hcl	Propranolol Hcl	35	suppressed
Sodium Chloride	0.9 % Sodium Chloride	35	13
Cephalexin	Cephalexin	34	20
Imipramine Hcl	Imipramine Hcl	34	suppressed
Diltiazem Hcl	Diltiazem Hcl	33	suppressed
Labetalol Hcl	Labetalol Hcl	33	suppressed
Diclofenac Sodium	Diclofenac Sodium	31	12
Esomeprazole Magnesium	Esomeprazole Magnesium	31	suppressed
Warfarin Sodium	Warfarin Sodium	31	suppressed
Alendronate Sodium	Alendronate Sodium	30	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	30	suppressed
Bethanechol Chloride	Bethanechol Chloride	30	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Levemir Flexpen	Insulin Detemir	30	suppressed
Mounjaro	Tirzepatide	30	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	30	16
Valacyclovir	Valacyclovir Hcl	30	suppressed
Ketoconazole	Ketoconazole	28	13
Nitroglycerin	Nitroglycerin	28	24
Olanzapine	Olanzapine	28	suppressed
Albuterol Sulfate	Albuterol Sulfate	27	13
Colchicine	Colchicine	26	suppressed
Metolazone	Metolazone	26	suppressed
Nifedipine Er	Nifedipine	26	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	26	suppressed
Pregabalin	Pregabalin	26	suppressed
Ramipril	Ramipril	26	suppressed
Silodosin	Silodosin	26	suppressed
Topiramate	Topiramate	26	suppressed
Vascepa	Icosapent Ethyl	25	suppressed
Leflunomide	Leflunomide	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	17
Clonidine Hcl	Clonidine Hcl	23	suppressed
Glimepiride	Glimepiride	23	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	23	suppressed
Trimethoprim	Trimethoprim	23	suppressed
Budesonide Er	Budesonide	22	suppressed
Bumetanide	Bumetanide	22	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	22	suppressed
Meloxicam	Meloxicam	22	suppressed
Metformin Hcl Er	Metformin Hcl	22	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	22	suppressed
Ozempic	Semaglutide	22	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Cefdinir	Cefdinir	21	16
Nitroglycerin Patch	Nitroglycerin	21	suppressed
Nystatin	Nystatin	21	16
Sucralfate	Sucralfate	21	suppressed
Tacrolimus	Tacrolimus	21	suppressed
Amoxicillin	Amoxicillin	20	11
Doxycycline Monohydrate	Doxycycline Monohydrate	20	13
Lovastatin	Lovastatin	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Mirabegron Er	Mirabegron	19	suppressed
Restasis Multidose	Cyclosporine	19	suppressed
Elmiron	Pentosan Polysulfate Sodium	18	suppressed
Insulin Lispro	Insulin Lispro	18	suppressed
Nyamyc	Nystatin	18	11
Trulicity	Dulaglutide	18	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	17	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	11
Methocarbamol	Methocarbamol	17	suppressed
Renacidin	Citric Ac/Gluconolact/Mag Carb	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Morphine Sulfate	Morphine Sulfate	16	suppressed
Mupirocin	Mupirocin	16	13
Naproxen	Naproxen	16	suppressed
Serevent Diskus	Salmeterol Xinafoate	16	suppressed
Insulin Aspart Flexpen	Insulin Aspart	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	13
Trospium Chloride	Trospium Chloride	15	suppressed
Atropine Sulfate	Atropine Sulfate	14	11
Bupivacaine Hcl	Bupivacaine Hcl/Pf	14	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	14	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	suppressed
Erythromycin	Erythromycin Base	14	suppressed
Estradiol	Estradiol	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Lidocaine Hcl	Lidocaine Hcl	14	13
Midodrine Hcl	Midodrine Hcl	14	suppressed
Pentoxifylline	Pentoxifylline	14	suppressed
Acetazolamide	Acetazolamide	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Diazepam	Diazepam	13	suppressed
Digoxin	Digoxin	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Indapamide	Indapamide	13	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Methylprednisolone Acetate	Methylprednisolone Acetate	13	suppressed
Nuplazid	Pimavanserin Tartrate	13	suppressed
Travoprost	Travoprost	13	suppressed
Carbidopa	Carbidopa	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Colestipol Hcl	Colestipol Hcl	12	suppressed
Metronidazole	Metronidazole	12	11
Mycophenolate Mofetil	Mycophenolate Mofetil	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Clonidine	Clonidine	11	suppressed
Fluorometholone	Fluorometholone	11	suppressed
Galantamine Hbr	Galantamine Hbr	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	11	suppressed
Premarin	Estrogens, Conjugated	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Sodium Chloride	Sodium Chloride 0.45 %	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$207.42 · 3 records	Otsuka Pharmaceutical Development & Commercialization, Inc.	COBENFY, NUPLAZID, REXULTI	2	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Nuplazid play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with ACADIA Pharmaceuticals Inc?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error